EGFR and non-small cell lung carcinoma: Similarly, high EGFR copy number, which occurs in 30–50% of patients with NSCLC, and gene amplification, which occurs in about 10% [41], have recently been shown to be €overruled€ by EGFR mutations with respect to their predictive value for the response to EGFR-TKIs [40].